USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
FIFTH BASE, LLC
Address:
200 Upland Road
Newton, MA 02460-2423
Phone:
N/A
URL:
N/A
EIN:
181067480
DUNS:
612534714
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $421,720.00 2
SBIR Phase II $1,415,731.00 1

Award List:

Prevention of Tumor Recurrence Following Surgical Resection

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$255,800.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): In 2007, lung cancer will be the number one cancer killer in the US with the identification of an estimated 213,380 new lung cancer cases. Roughly one-quarter of these patients will be considered candidates for potentia lly curative surgical resection. The extent… More

Functional Vectors for Treatment of Mesothelioma

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$165,920.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Gene therapy offers the potential to cure or prevent diseases by delivering a therapeutic gene into a host. Gene delivery can effectively stimulate the body's immune response and prevent or control infection. Consequent ly, gene therapy is under investigation for… More

Prevention of Tumor Recurrence Following Surgical Resection (Phase II)

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$1,415,731.00
Agency:
HHS
Principal Investigator:
Jesse B. Wolinsky – 617-817-4558
Abstract:
DESCRIPTION (provided by applicant): In 2009, there were 219,000 new lung cancer cases reported. Roughly one-quarter of these patients will be considered candidates for curative surgical resection, where the preservation of lung function must be balanced against the extent of tissue removed. As a… More